Page last updated: 2024-08-24

fluorodeoxyglucose f18 and Neurodegenerative Diseases

fluorodeoxyglucose f18 has been researched along with Neurodegenerative Diseases in 79 studies

Research

Studies (79)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	2 (2.53)	18.2507
2000's	11 (13.92)	29.6817
2010's	42 (53.16)	24.3611
2020's	24 (30.38)	2.80

Authors

Authors	Studies
Bartenstein, P; Baumann, K; Beyer, L; Biechele, G; Blume, T; Brendel, M; Briel, N; Buerger, K; Deussing, M; Drzezga, A; Eckenweber, F; Franzmeier, N; Gildehaus, FJ; Haass, C; Herms, J; Höglinger, GU; Lammich, S; Levin, J; Lindner, S; Palleis, C; Perneczky, R; Rauchmann, BS; Respondek, G; Ribicic, S; Rominger, A; Shi, Y; Spitz, C; Tahirovic, S; Wiedemann, T; Willem, M; Wind, K; Xiang, X; Zatcepin, A; Ziegler, S	1
Ko, JH; Strafella, AP	1
Arivazhagan, A; Asranna, A; Bharath, RD; Iyer, V; Kulanthaivelu, K; Mahadevan, A; Mangalore, S; Mhatre, R; Mundlamuri, R; Nagaraj, C; Raghavendra, K; Rao, MB; Sadashiva, N; Saini, J; Sinha, S; Vivek S, M	1
Calhoun, VD; Dalenberg, JR; De Jong, BM; de Vries, JJ; Kok, JG; Kremer, HPH; Meles, SK; Qi, S; Renken, RJ; Siero, JCW; Spikman, JM; van der Horn, HJ; Vergara, VM	1
Cross, D; Drzezga, A; Foster, NL; Minoshima, S; Thientunyakit, T	1
Álvarez-Sanchez, L; Aparici-Robles, F; Baquero-Toledo, M; Cerdá-Alberich, L; Cháfer-Pericás, C; Gandia-Ferrero, MT; Gómez-Rico, I; Martí-Bonmatí, L; Martínez-Sanchis, B; Prats-Climent, J; Rodríguez-Álvarez, MJ; Torres-Espallardo, I	1
Alavi, A; Coble, R; Khosravi, M; Newberg, AB	1
Biehl, M; de Vries, GJ; Janzen, A; Leenders, KL; Meles, SK; Oertel, WH; Reesink, FE; Renken, RJ; van Veen, R	1
Brendel, M; Haass, C; Tahirovic, S; Xiang, X; Ziegler, S	1
Nordberg, A; Pascoal, TA; Pellerin, L; Rosa-Neto, P; Zimmer, ER	1
Agnello, L; Blandino, V; Ciaccio, M; Colletti, T; Gambino, CM; Giglio, RV; Graziano, F; Guajana, F; La Bella, V; Lo Sasso, B; Maniscalco, L; Matranga, D; Piccoli, T	1
Bartenstein, P; Barthel, H; Beyer, L; Brendel, M; Bui, N; Cumming, P; Eckenweber, F; Franzmeier, N; Hong, J; Katzdobler, S; Levin, J; Palleis, C; Patt, M; Perneczky, R; Rauchmann, BS; Rominger, A; Sabri, O; Scheifele, M; Shi, K; Völter, F	1
Carlos, AF; Crum, BA; Graff-Radford, J; Josephs, KA; Lowe, VJ; Machulda, MM; Pham, NTT; Whitwell, JL	1
Blennow, K; Cortes-Canteli, M; Fernandez-Ortiz, A; Fuster, V; Garcia-Alvarez, A; Garcia-Lunar, I; Gispert, JD; Ibanez, B; Moreno-Arciniegas, A; Moro, MA; Oliva, B; Perez-Herreras, C; Sanchez-Gonzalez, J; Schöll, M; Suárez-Calvet, M; Tristão-Pereira, C; Zetterberg, H	1
Jamšek, J; Mlakar, J; Rus, T; Trošt, M	1
Blazhenets, G; Frings, L; Maurer, C; Meyer, PT; Rau, A; Schröter, N; Urbach, H	1
Brucki, SMD; Coutinho, AM; DE Brito, MH; Zampieri, PF	1
Danfors, T; Hansson, O; Jögi, J; Lindström, E; Lubberink, M; Oddstig, J	1
Anile, C; Calcagni, ML; Mangiola, A; Mattoli, MV; Treglia, G; Trevisi, G	1
Breining, BL; Hillis, AE	1
Berti, V; Cappa, SF; Catricalà, E; Conca, F; Esposito, V; Filippi, M; Gasparri, C; Iannaccone, S; Magnani, G; Perani, D; Polito, C; Presotto, L; Pupi, A; Sala, A; Sorbi, S	1
Ahmed, O; Bangiyev, L; Clifton, MA; Clouston, S; Franceschi, AM; Franceschi, D; Naser-Tavakolian, K	1
Dave, A; Downey, R; Hansen, N; Johnson, C	1
De Vincentis, G; Frantellizzi, V; Madeddu, G; Nuvoli, S; Palumbo, B; Spanu, A; Stazza, ML; Tanda, G	1
Aarsland, D; Agudelo-Cifuentes, M; Bauckneht, M; Brendel, M; Bruffaerts, R; Byttner, S; Camacho, V; Chang, JR; Chincarini, A; Davidsson, A; Etminani, K; Frisoni, GB; Garibotto, V; Kramberger, MG; Lemstra, AW; Martínez-Sanchis, B; Morbelli, S; Nicastro, N; Nobili, F; Ochoa-Figueroa, M; Padovani, A; Pilotto, A; Ressner, M; Rominger, A; Soliman, A; Stegeran, R; Trost, M; van Berckel, BNM; Vandenberghe, R	1
Bejanin, A; Horng, A; Jagust, WJ; Landau, SM; Lockhart, SN; Schreiber, F; Schreiber, S	1
Claassen, DO; Samson, M	1
Bartenstein, P; Blautzik, J; Brendel, M; Ishii, K; Kotz, S; Rominger, A; Sauerbeck, J; Vettermann, F; Winter, Y	1
Bischof, GN; Drzezga, A; Endepols, H; van Eimeren, T	1
Bischof, GN; Drzezga, A; Hammes, J; Leuwer, I; van Eimeren, T	1
Carriò, I; Frisoni, GB; Nobili, F; Schmidt, R	1
Agosta, F; Altomare, D; Arbizu, J; Boccardi, M; Bouwman, F; Drzezga, A; Festari, C; Nestor, P; Nobili, F; Orini, S; Van Laere, K; Walker, Z	1
Agosta, F; Arbizu, J; Boccardi, M; Bouwman, F; Drzezga, A; Nestor, P; Nobili, F; Walker, Z	1
Abrunhosa, A; Barroca, D; Cardoso, E; Castelo-Branco, M; Cruz, Â; de Mendonça, A; Moreira, AP; Oliveira, FPM; Rio, J; Verdelho, A; Xavier, C	1
Gianolli, L; Luzi, L; Malpetti, M; Perani, D; Sala, A; Vanoli, EG	1
Boxer, AL; Cho, H; Choi, JY; Gorno-Tempini, ML; Hansson, O; Janelidze, S; Jögi, J; Kramer, J; La Joie, R; Lyoo, CH; Mattsson, N; Miller, BL; Ohlsson, T; Ossenkoppele, R; Palmqvist, S; Rabinovici, GD; Ryu, YH; Santillo, A; Schöll, M; Smith, R; Strandberg, O; Tsai, R	1
Ghetti, B; Grafman, J; Huey, ED; Kreisl, WC; Morbelli, S; Nobili, F; Pardini, M; Spina, S; Wassermann, EM	1
Anatharam, V; Clark, BE; Kanthasamy, A; Klinedinst, B; McLimans, KE; Pappas, C; Plagman, A; Willette, AA	1
Domschke, K; Hellwig, S; Meyer, PT	1
Alessandrini, M; Bruno, E; Chiaravalloti, A; Ciccariello, G; Micarelli, A; Pagani, M; Ricci, M; Schillaci, O	1
Duffy, JR; Jack, CR; Josephs, KA; Lowe, VJ; Machulda, MM; Mandrekar, J; Senjem, ML; Strand, EA; Whitwell, JL; Xia, R	1
Dhawan, V; Eidelberg, D; Ko, JH; Ma, Y; Peng, S; Spetsieris, P; Tang, CC	1
Davison, CM; O'Brien, JT	1
Gregg, BE; Gunter, JL; Jack, CR; Jones, DT; Knopman, DS; Lowe, V; Mielke, MM; Pankratz, VS; Petersen, RC; Senjem, ML; Vemuri, P; Weigand, SD; Wiste, HJ	1
Haase, CM; Jagust, WJ; Landau, SM; Madison, CM; Oh, H; Rabinovici, GD; Villeneuve, S; Wirth, M	1
D'Souza, MM; Damle, N; Jaimini, A; Kushwaha, S; Mondal, A; Saw, S; Sharma, R; Tripathi, M	1
Cappa, SF; Cerami, C; Coppi, E; Crespi, C; Della Rosa, PA; Dodich, A; Falini, A; Magnani, G; Marcone, A; Perani, D	1
Colletti, PM; Grassetto, G; Marzola, MC; Musto, A; Perkins, AC; Rubello, D; Viniamury, S	1
Allen, PJ; Amtage, F; Eidelberg, D; Feigin, A; Hanspal, E; Heinen, L; Hellwig, S; Leenders, KL; Meyer, PT; Niethammer, M; Poston, KL; Tang, CC; Vonsattel, JP	1
Cappa, SF; Castiglioni, I; Cerami, C; Della Rosa, PA; Fallanca, F; Gallivanone, F; Garibotto, V; Gianolli, L; Magnani, G; Marcone, A; Nobili, F; Panzacchi, A; Pappatà, S; Perani, D; Vanoli, EG	1
Capriotti, G; Pagani, M; Sonni, I	1
Dunn, JT; Lin, JP; O'Doherty, MJ; Reed, L; Szyszko, TA	1
Goldstein, DS; Holmes, C; Kopin, IJ; Mash, DC; Sharabi, Y; Sidransky, E; Stefani, A; Sullivan, P	1
Beaunieux, H; Chételat, G; Desgranges, B; Eustache, F; La Joie, R; Pitel, AL; Ritz, L; Segobin, S	1
Boecker, H; Drzezga, AE; Götz, J; Granert, O; Häussermann, P; Kurz, A; Perneczky, R; van Eimeren, T	1
Boeve, BF; Gunter, JL; Jack, CR; Jones, DT; Kantarci, K; Knopman, DS; Lowe, VJ; Lundt, ES; Machulda, MM; Mielke, MM; Petersen, RC; Roberts, RO; Senjem, ML; Vemuri, P; Weigand, SD; Wiste, HJ	1
Diehl-Schmid, J; Drzezga, A; Förster, S; Grimmer, T; Meng, C; Riedl, V; Shao, J; Sorg, C; Tahmasian, M; Yousefi, BH	1
de Ceballos, ML; Köfalvi, A	1
Alongi, P; Caminiti, SP; Cerami, C; Comi, G; Gianolli, L; Majno, L; Perani, D; Volontè, MA	1
Coppola, C; Cotrufo, R; Di Fede, G; Formisano, S; Giaccone, G; Lavorgna, A; Leonardi, A; Mauro, C; Nigro, M; Piscosquito, G; Puoti, G; Tagliavini, F	1
Chang, KW; Chen, CC; Lee, SY; Wang, HE	1
Apostolova, I; Arlt, S; Buchert, R; Jahn, H; Thiele, F; Wenzel, F; Wilke, F; Young, S	1
Shulman, A; Strashun, AM	1
Bartels, AL; de Jong, BM; de Vries, JJ; Eshuis, SA; Leenders, KL; Teune, LK; van Oostrom, JC; Willemsen, AT	1
Duffy, JR; Jack, CR; Josephs, KA; Lowe, VJ; Machulda, MM; Master, AV; Senjem, ML; Strand, EA; Whitwell, JL	1
Brockmann, K; Globas, C; Hauser, TK; Machulla, HJ; Reimold, M; Rolfs, A; Schöls, L; Walter, U	1
Lewis, DH; Minoshima, S; Vesselle, H; Zhang, Y	1
Tobe, E	1
Amtage, F; Buchert, R; Hellwig, B; Hellwig, S; Kreft, A; Meyer, PT; Rijntjes, M; Spehl, TS; Tüscher, O; Vach, W; Weber, WA; Weiller, C; Winkler, C; Winz, OH	1
Chin, J; Heilman, KM; Kang, SJ; Kwon, JC; Lee, BH; Na, DL	1
Silverman, DH	1
Alexopoulos, P; Domes, G; Grimmer, T; Kurz, A; Perneczky, R	1
Hummel, T; Kitzler, H; Landis, B; Mueller, A; Reichmann, H; Reuner, U	1
Donadieu, J; Hoang-Xuan, K; Idbaih, A; Martin-Duverneuil, N; Remy, P; Ribeiro, MJ; Samson, Y; Thomas, C	1
Al-Essa, M; Al-Shamsan, L; Al-Sonbul, A; Al-Watban, J; Bakheet, S; Ozand, PT; Patay, Z; Powe, J	1
al-Essa, MA; al-Shamsan, LA; Ozand, PT	1
Bodart, JM; De Volder, A; Laterre, C; Lutte, I	1
Degueldre, C; Destée, A; Franck, G; Garraux, G; Kreisler, A; Lemaire, C; Peigneux, P; Salmon, E	1
Hirono, N; Hosaka, K; Ishii, K; Mori, E; Mori, T; Sakamoto, S; Sasaki, M	1

Reviews

14 review(s) available for fluorodeoxyglucose f18 and Neurodegenerative Diseases

Article	Year
Metabolic imaging and plasticity. Handbook of clinical neurology, 2022, Volume: 184 Topics: Brain; Fluorodeoxyglucose F18; Humans; Neurodegenerative Diseases; Parkinson Disease; Parkinsonian Disorders; Positron-Emission Tomography	2022
Positron Emission Tomography-Based Assessment of Cognitive Impairment and Dementias, Critical Role of Fluorodeoxyglucose in such Settings. PET clinics, 2022, Volume: 17, Issue:3 Topics: Cognitive Dysfunction; Dementia; Fluorodeoxyglucose F18; Humans; Neurodegenerative Diseases; Positron-Emission Tomography; Radiopharmaceuticals	2022
Usefulness of Brain Positron Emission Tomography with Different Tracers in the Evaluation of Patients with Idiopathic Normal Pressure Hydrocephalous. International journal of molecular sciences, 2020, Sep-07, Volume: 21, Issue:18 Topics: Alzheimer Disease; Amyloid; Amyloidogenic Proteins; Brain; Cerebrovascular Circulation; Fluorodeoxyglucose F18; Humans; Hydrocephalus, Normal Pressure; Neurodegenerative Diseases; Positron-Emission Tomography; tau Proteins; Ventriculoperitoneal Shunt	2020
FDG-PET Imaging of Dementia and Neurodegenerative Disease. Seminars in ultrasound, CT, and MR, 2020, Volume: 41, Issue:6 Topics: Brain; Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Neurodegenerative Diseases; Positron-Emission Tomography; Radiopharmaceuticals	2020
Neurodegeneration and the Cerebellum. Neuro-degenerative diseases, 2017, Volume: 17, Issue:4-5 Topics: Aged; Cerebellar Diseases; Cerebellum; Cognition Disorders; Fluorodeoxyglucose F18; Humans; Male; Neural Pathways; Neurodegenerative Diseases; Positron-Emission Tomography	2017
Tau-imaging in neurodegeneration. Methods (San Diego, Calif.), 2017, 11-01, Volume: 130 Topics: Animals; Brain; Fluorodeoxyglucose F18; Humans; Neurodegenerative Diseases; Positron Emission Tomography Computed Tomography; Protein Binding; tau Proteins; Tauopathies	2017
Automated assessment of FDG-PET for differential diagnosis in patients with neurodegenerative disorders. European journal of nuclear medicine and molecular imaging, 2018, Volume: 45, Issue:9 Topics: Dementia; Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Neurodegenerative Diseases; Positron-Emission Tomography; Sensitivity and Specificity	2018
Update on PET in neurodegenerative and neuroinflammatory disorders manifesting on a behavioural level: imaging for differential diagnosis. Current opinion in neurology, 2019, Volume: 32, Issue:4 Topics: Alzheimer Disease; Brain; Diagnosis, Differential; Fluorodeoxyglucose F18; Glucose; Humans; Inflammation; Neurodegenerative Diseases; Neuroimaging; Positron-Emission Tomography; Prospective Studies	2019
Evaluation of Task-Related Brain Activity: Is There a Role for BioMed research international, 2019, Volume: 2019 Topics: Cerebral Cortex; Fluorodeoxyglucose F18; Humans; Neurodegenerative Diseases; Positron-Emission Tomography; Radiopharmaceuticals	2019
A comparison of FDG-PET and blood flow SPECT in the diagnosis of neurodegenerative dementias: a systematic review. International journal of geriatric psychiatry, 2014, Volume: 29, Issue:6 Topics: Dementia; Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Neurodegenerative Diseases; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed, Single-Photon	2014
Non-Alzheimer types of neurodegenerative dementia: clinical and 18F-FDG-PET/CT pictures. Nuclear medicine communications, 2014, Volume: 35, Issue:11 Topics: Dementia; Fluorodeoxyglucose F18; Functional Neuroimaging; Humans; Neurodegenerative Diseases; Positron-Emission Tomography; Tomography, X-Ray Computed	2014
FDG-PET Contributions to the Pathophysiology of Memory Impairment. Neuropsychology review, 2015, Volume: 25, Issue:3 Topics: Aging; Alcoholism; Alzheimer Disease; Amyloid beta-Peptides; Atrophy; Brain; Female; Fluorodeoxyglucose F18; Glucose; Gray Matter; Humans; Image Processing, Computer-Assisted; Memory Disorders; Middle Aged; Neurodegenerative Diseases; Positron-Emission Tomography; Signal Processing, Computer-Assisted	2015
Fluid dynamics vascular theory of brain and inner-ear function in traumatic brain injury: a translational hypothesis for diagnosis and treatment. The international tinnitus journal, 2009, Volume: 15, Issue:2 Topics: Blood-Brain Barrier; Brain Injuries; Brain Ischemia; Cerebrospinal Fluid Pressure; Cochlea; Ear, Inner; Endolymph; Endolymphatic Hydrops; Fluid Shifts; Fluorodeoxyglucose F18; Hearing Disorders; Homeostasis; Humans; Inflammation Mediators; Meniere Disease; Neurodegenerative Diseases; Neurotransmitter Agents; Perilymph; Positron-Emission Tomography; Pseudotumor Cerebri; Tomography, Emission-Computed, Single-Photon; Vestibule, Labyrinth	2009
Brain 18F-FDG PET in the diagnosis of neurodegenerative dementias: comparison with perfusion SPECT and with clinical evaluations lacking nuclear imaging. Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2004, Volume: 45, Issue:4 Topics: Brain; Dementia; Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Neurodegenerative Diseases; Practice Patterns, Physicians'; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, Emission-Computed, Single-Photon	2004

Trials

3 trial(s) available for fluorodeoxyglucose f18 and Neurodegenerative Diseases

Article	Year
Manual approach during hand gesture imitation. Archives of neurology, 2002, Volume: 59, Issue:9 Topics: Aged; Apraxias; Behavior; Fluorodeoxyglucose F18; Frontal Lobe; Gestures; Hand; Hand Strength; Humans; Male; Memory, Short-Term; Movement; Neurodegenerative Diseases; Radiopharmaceuticals; Tomography, Emission-Computed	2002
18Fluoro-2-deoxyglucose (18FDG) PET scan of the brain in propionic acidemia: clinical and MRI correlations. Brain & development, 1999, Volume: 21, Issue:5 Topics: Brain; Carbohydrate Metabolism, Inborn Errors; Child, Preschool; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Neurodegenerative Diseases; Propionates; Radiopharmaceuticals; Tomography, Emission-Computed	1999
Voxel-based comparison of regional cerebral glucose metabolism between PSP and corticobasal degeneration. Journal of the neurological sciences, 2002, Jul-15, Volume: 199, Issue:1-2 Topics: Brain; Caudate Nucleus; Dementia; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Frontal Lobe; Glucose; Humans; Male; Mesencephalon; Middle Aged; Neurodegenerative Diseases; Neuropsychological Tests; Occipital Lobe; Parietal Lobe; Parkinsonian Disorders; Predictive Value of Tests; Reference Values; Somatosensory Cortex; Supranuclear Palsy, Progressive; Tomography, Emission-Computed	2002

Other Studies

62 other study(ies) available for fluorodeoxyglucose f18 and Neurodegenerative Diseases

Article	Year
Microglial activation states drive glucose uptake and FDG-PET alterations in neurodegenerative diseases. Science translational medicine, 2021, Oct-13, Volume: 13, Issue:615 Topics: Animals; Fluorodeoxyglucose F18; Glucose; Humans; Mice; Microglia; Neurodegenerative Diseases; Positron-Emission Tomography	2021
Rasmussen's encephalitis: Imaging spectrum on simultaneous FDG-PET and MRI imaging correlation. Clinical imaging, 2022, Volume: 85 Topics: Adult; Atrophy; Child; Encephalitis; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Neurodegenerative Diseases	2022
A resting-state fMRI pattern of spinocerebellar ataxia type 3 and comparison with NeuroImage. Clinical, 2022, Volume: 34 Topics: Fluorodeoxyglucose F18; Humans; Machado-Joseph Disease; Magnetic Resonance Imaging; Neurodegenerative Diseases; Positron-Emission Tomography	2022
Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2022, Volume: 63, Issue:Suppl 1 Topics: Aged; Alzheimer Disease; Fluorodeoxyglucose F18; Frontotemporal Dementia; Glucose; Humans; Neurodegenerative Diseases; Positron-Emission Tomography	2022
Artificial Intelligence on FDG PET Images Identifies Mild Cognitive Impairment Patients with Neurodegenerative Disease. Journal of medical systems, 2022, Jun-17, Volume: 46, Issue:8 Topics: Alzheimer Disease; Artificial Intelligence; Cognitive Dysfunction; Fluorodeoxyglucose F18; Frontotemporal Dementia; Humans; Neurodegenerative Diseases; Positron-Emission Tomography	2022
FDG-PET combined with learning vector quantization allows classification of neurodegenerative diseases and reveals the trajectory of idiopathic REM sleep behavior disorder. Computer methods and programs in biomedicine, 2022, Volume: 225 Topics: Fluorodeoxyglucose F18; Humans; Neurodegenerative Diseases; Parkinson Disease; Positron-Emission Tomography; REM Sleep Behavior Disorder	2022
Response to Comment on "Microglial activation states drive glucose uptake and FDG-PET alterations in neurodegenerative diseases". Science translational medicine, 2022, 08-24, Volume: 14, Issue:659 Topics: Fluorodeoxyglucose F18; Glucose; Humans; Microglia; Neurodegenerative Diseases; Positron-Emission Tomography	2022
Comment on "Microglial activation states drive glucose uptake and FDG-PET alterations in neurodegenerative diseases". Science translational medicine, 2022, 08-24, Volume: 14, Issue:659 Topics: Fluorodeoxyglucose F18; Glucose; Humans; Microglia; Neurodegenerative Diseases; Positron-Emission Tomography	2022
Biomarkers Related to Synaptic Dysfunction to Discriminate Alzheimer's Disease from Other Neurological Disorders. International journal of molecular sciences, 2022, Sep-16, Volume: 23, Issue:18 Topics: alpha-Synuclein; Alzheimer Disease; Amyloid beta-Peptides; Biomarkers; Cognitive Dysfunction; Fluorodeoxyglucose F18; Humans; Neurodegenerative Diseases; Neurogranin; tau Proteins	2022
Assessment of perfusion deficit with early phases of [ European journal of nuclear medicine and molecular imaging, 2023, Volume: 50, Issue:5 Topics: Alzheimer Disease; Amyloid; Aniline Compounds; Brain; Fluorodeoxyglucose F18; Humans; Neurodegenerative Diseases; Perfusion; Positron-Emission Tomography	2023
Antiphospholipid syndrome mimicking posterior cortical atrophy and the "railroad track" sign on brain fluorodeoxyglucose-positron emission tomography. Journal of the neurological sciences, 2023, 05-15, Volume: 448 Topics: Antiphospholipid Syndrome; Atrophy; Brain; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Neurodegenerative Diseases; Positron-Emission Tomography; Radiopharmaceuticals; Railroads	2023
Longitudinal interplay between subclinical atherosclerosis, cardiovascular risk factors, and cerebral glucose metabolism in midlife: results from the PESA prospective cohort study. The lancet. Healthy longevity, 2023, Volume: 4, Issue:9 Topics: Atherosclerosis; Cardiovascular Diseases; Carotid Artery Diseases; Female; Fluorodeoxyglucose F18; Glucose; Heart Disease Risk Factors; Humans; Longitudinal Studies; Male; Middle Aged; Neurodegenerative Diseases; Prospective Studies; Risk Factors	2023
Metabolic Brain Changes Can Predict the Underlying Pathology in Neurodegenerative Brain Disorders: A Case Report of Sporadic Creutzfeldt-Jakob Disease with Concomitant Parkinson's Disease. International journal of molecular sciences, 2023, Aug-23, Volume: 24, Issue:17 Topics: Aged; Brain; Creutzfeldt-Jakob Syndrome; Fluorodeoxyglucose F18; Humans; Neurodegenerative Diseases; Parkinson Disease	2023
The metabolic spatial covariance pattern of definite idiopathic normal pressure hydrocephalus: an FDG PET study with principal components analysis. Alzheimer's research & therapy, 2023, 11-18, Volume: 15, Issue:1 Topics: Alzheimer Disease; Brain; Fluorodeoxyglucose F18; Humans; Hydrocephalus, Normal Pressure; Neurodegenerative Diseases; Positron-Emission Tomography	2023
Brain [18F]FDG PET-CT imaging in posterior cortical atrophy. Arquivos de neuro-psiquiatria, 2019, Volume: 77, Issue:10 Topics: Aged; Atrophy; Cerebral Cortex; Fluorodeoxyglucose F18; Humans; Male; Neurodegenerative Diseases; Neuroimaging; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals	2019
Image reconstruction methods affect software-aided assessment of pathologies of [ NeuroImage. Clinical, 2020, Volume: 28 Topics: Aniline Compounds; Benzothiazoles; Brain; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Neurodegenerative Diseases; Positron-Emission Tomography; Software; Tomography, X-Ray Computed	2020
Across diagnoses, naming errors reflect the location of damage. Neurology, 2020, 11-17, Volume: 95, Issue:20 Topics: Fluorodeoxyglucose F18; Humans; Neurodegenerative Diseases; Semantics; Verbal Behavior	2020
Neural correlates of naming errors across different neurodegenerative diseases: An FDG-PET study. Neurology, 2020, 11-17, Volume: 95, Issue:20 Topics: Aged; Aged, 80 and over; Alzheimer Disease; Aphasia, Primary Progressive; Connectome; Dementia; Female; Fluorodeoxyglucose F18; Frontotemporal Dementia; Humans; Language; Male; Neurodegenerative Diseases; Occipital Lobe; Pattern Recognition, Visual; Positron-Emission Tomography; Retrospective Studies; Semantics; Speech; Supranuclear Palsy, Progressive; Temporal Lobe	2020
FDG PET/MRI for Visual Detection of Crossed Cerebellar Diaschisis in Patients With Dementia. AJR. American journal of roentgenology, 2021, Volume: 216, Issue:1 Topics: Aged; Cerebellum; Dementia; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Neurodegenerative Diseases; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies	2021
123I-Ioflupane SPECT and 18F-FDG PET Combined Use in the Characterization of Movement and Cognitive Associated Disorders in Neurodegenerative Diseases. Current Alzheimer research, 2021, Volume: 18, Issue:3 Topics: Alzheimer Disease; Brain; Cognition Disorders; Fluorodeoxyglucose F18; Humans; Movement Disorders; Neurodegenerative Diseases; Nortropanes; Parkinson Disease; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Tomography, Emission-Computed, Single-Photon	2021
A 3D deep learning model to predict the diagnosis of dementia with Lewy bodies, Alzheimer's disease, and mild cognitive impairment using brain 18F-FDG PET. European journal of nuclear medicine and molecular imaging, 2022, Volume: 49, Issue:2 Topics: Alzheimer Disease; Brain; Cognitive Dysfunction; Deep Learning; Fluorodeoxyglucose F18; Humans; Lewy Body Disease; Neurodegenerative Diseases; Positron-Emission Tomography; Retrospective Studies	2022
Alzheimer Disease Signature Neurodegeneration and APOE Genotype in Mild Cognitive Impairment With Suspected Non-Alzheimer Disease Pathophysiology. JAMA neurology, 2017, 06-01, Volume: 74, Issue:6 Topics: Aged; Aged, 80 and over; Alzheimer Disease; Amyloid beta-Peptides; Aniline Compounds; Apolipoproteins E; Biomarkers; Cerebral Cortex; Cognitive Dysfunction; Disease Progression; Ethylene Glycols; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Hippocampus; Humans; Magnetic Resonance Imaging; Male; Neurodegenerative Diseases; Parietal Lobe; Positron-Emission Tomography; Temporal Lobe	2017
Relationship Between Body Mass Index, ApoE4 Status, and PET-Based Amyloid and Neurodegeneration Markers in Amyloid-Positive Subjects with Normal Cognition or Mild Cognitive Impairment. Journal of Alzheimer's disease : JAD, 2018, Volume: 65, Issue:3 Topics: Adaptor Proteins, Signal Transducing; Aged; Amyloid; Aniline Compounds; Apolipoprotein E4; Body Mass Index; Brain; Cognition; Cognitive Dysfunction; Ethylene Glycols; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Glucose; Heterozygote; Humans; Male; Neurodegenerative Diseases; Positron-Emission Tomography; Radiopharmaceuticals; Repressor Proteins; Weight Loss; Zebrafish Proteins	2018
Multimodal correlation of dynamic [ European journal of nuclear medicine and molecular imaging, 2017, Volume: 44, Issue:13 Topics: Carbolines; Fluorodeoxyglucose F18; Humans; Neurodegenerative Diseases; Neurons; Perfusion Imaging; Positron-Emission Tomography	2017
Brain FDG-PET: clinical use in dementing neurodegenerative conditions. European journal of nuclear medicine and molecular imaging, 2018, Volume: 45, Issue:9 Topics: Brain; Fluorodeoxyglucose F18; Humans; Neurodegenerative Diseases; Positron-Emission Tomography; Radiopharmaceuticals	2018
European Association of Nuclear Medicine and European Academy of Neurology recommendations for the use of brain European journal of neurology, 2018, Volume: 25, Issue:10 Topics: Brain; Cognitive Dysfunction; Consensus; Dementia; Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Neurodegenerative Diseases; Nuclear Medicine; Positron-Emission Tomography; Sensitivity and Specificity	2018
Can 11C-PiB-PET Relative Delivery R1 or 11C-PiB-PET Perfusion Replace 18F-FDG-PET in the Assessment of Brain Neurodegeneration? Journal of Alzheimer's disease : JAD, 2018, Volume: 65, Issue:1 Topics: Aged; Aged, 80 and over; Algorithms; Alzheimer Disease; Brain; Carbon Radioisotopes; Cognition Disorders; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neurodegenerative Diseases; Positron-Emission Tomography; Tomography Scanners, X-Ray Computed	2018
Unfavourable gender effect of high body mass index on brain metabolism and connectivity. Scientific reports, 2018, 08-22, Volume: 8, Issue:1 Topics: Aged; Aged, 80 and over; Alzheimer Disease; Body Mass Index; Brain; Female; Fluorodeoxyglucose F18; Humans; Male; Membrane Potentials; Neural Pathways; Neurodegenerative Diseases; Neuropsychological Tests; Obesity; Positron-Emission Tomography; Risk Factors; Sex Factors	2018
Discriminative Accuracy of [18F]flortaucipir Positron Emission Tomography for Alzheimer Disease vs Other Neurodegenerative Disorders. JAMA, 2018, 09-18, Volume: 320, Issue:11 Topics: Adult; Aged; Aged, 80 and over; Alzheimer Disease; Amyloid beta-Peptides; Area Under Curve; Carbolines; Cerebral Cortex; Cognitive Dysfunction; Cross-Sectional Studies; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neurodegenerative Diseases; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity	2018
FDG-PET patterns associated with underlying pathology in corticobasal syndrome. Neurology, 2019, 03-05, Volume: 92, Issue:10 Topics: Brain; Brain Diseases; Cohort Studies; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neurodegenerative Diseases; Positron-Emission Tomography; Radiopharmaceuticals; Syndrome	2019
Is Cerebrospinal Fluid Superoxide Dismutase 1 a Biomarker of Tau But Not Amyloid-Induced Neurodegeneration in Alzheimer's Disease? Antioxidants & redox signaling, 2019, 09-10, Volume: 31, Issue:8 Topics: Aged; Aged, 80 and over; Alzheimer Disease; Amyloid; Amyloid beta-Peptides; Apolipoproteins E; Biomarkers; Cognition; Disease Susceptibility; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Memory; Neurodegenerative Diseases; Positron-Emission Tomography; Superoxide Dismutase-1; tau Proteins	2019
Distinct regional anatomic and functional correlates of neurodegenerative apraxia of speech and aphasia: an MRI and FDG-PET study. Brain and language, 2013, Volume: 125, Issue:3 Topics: Aged; Aphasia; Apraxias; Female; Fluorodeoxyglucose F18; Humans; Language Tests; Magnetic Resonance Imaging; Male; Neurodegenerative Diseases; Neuropsychological Tests; Positron-Emission Tomography; Radiopharmaceuticals	2013
Identification of disease-related spatial covariance patterns using neuroimaging data. Journal of visualized experiments : JoVE, 2013, Jun-26, Issue:76 Topics: Algorithms; Biomarkers; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Multivariate Analysis; Neurodegenerative Diseases; Neuroimaging; Positron-Emission Tomography; Principal Component Analysis; Radiopharmaceuticals	2013
Amyloid-first and neurodegeneration-first profiles characterize incident amyloid PET positivity. Neurology, 2013, Nov-12, Volume: 81, Issue:20 Topics: Aged; Aged, 80 and over; Alzheimer Disease; Amyloid; Brain; Cognition Disorders; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Image Processing, Computer-Assisted; Incidence; Magnetic Resonance Imaging; Male; Neurodegenerative Diseases; Oxygen; Positron-Emission Tomography	2013
Associations between Alzheimer disease biomarkers, neurodegeneration, and cognition in cognitively normal older people. JAMA neurology, 2013, Volume: 70, Issue:12 Topics: Aged; Aged, 80 and over; Alzheimer Disease; Aniline Compounds; Biomarkers; Cognition Disorders; Cohort Studies; Community-Based Participatory Research; Cross-Sectional Studies; Female; Fluorodeoxyglucose F18; Hippocampus; Humans; Magnetic Resonance Imaging; Male; Nerve Fibers, Myelinated; Neurodegenerative Diseases; Neuropsychological Tests; Positron-Emission Tomography; Psychiatric Status Rating Scales; Thiazoles	2013
Differential diagnosis of neurodegenerative dementias using metabolic phenotypes on F-18 FDG PET/CT. The neuroradiology journal, 2014, Volume: 27, Issue:1 Topics: Aged; Alzheimer Disease; Creutzfeldt-Jakob Syndrome; Dementia; Dementia, Vascular; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Frontotemporal Dementia; Humans; Lewy Body Disease; Male; Middle Aged; Neurodegenerative Diseases; Neuropsychological Tests; Phenotype; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Tomography, X-Ray Computed	2014
Brain changes within the visuo-spatial attentional network in posterior cortical atrophy. Journal of Alzheimer's disease : JAD, 2015, Volume: 43, Issue:2 Topics: Aged; Atrophy; Attention Deficit Disorder with Hyperactivity; Cerebral Cortex; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Mental Status Schedule; Middle Aged; Neurodegenerative Diseases; Neuropsychological Tests; Perceptual Disorders; Photic Stimulation; Positron-Emission Tomography; Space Perception	2015
A disease-specific metabolic brain network associated with corticobasal degeneration. Brain : a journal of neurology, 2014, Volume: 137, Issue:Pt 11 Topics: Aged; Aged, 80 and over; Basal Ganglia Diseases; Cerebral Cortex; Cerebrum; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Male; Metabolic Networks and Pathways; Middle Aged; Multiple System Atrophy; Nerve Net; Neurodegenerative Diseases; Parkinsonian Disorders; Positron-Emission Tomography; Reproducibility of Results; Sensitivity and Specificity; Supranuclear Palsy, Progressive	2014
Validation of an optimized SPM procedure for FDG-PET in dementia diagnosis in a clinical setting. NeuroImage. Clinical, 2014, Volume: 6 Topics: Aged; Aged, 80 and over; Brain; Data Interpretation, Statistical; Diagnosis, Computer-Assisted; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neurodegenerative Diseases; Positron-Emission Tomography; Sensitivity and Specificity	2014
Functional imaging in neurodegenerative disorders: past, present and future. The quarterly journal of nuclear medicine and molecular imaging : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology (IAR), [and] Section of the Society of..., 2014, Volume: 58, Issue:4 Topics: Cognition Disorders; Diagnostic Imaging; Dihydroxyphenylalanine; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Neurodegenerative Diseases; Positron-Emission Tomography	2014
Role of ¹⁸F-FDG PET imaging in paediatric primary dystonia and dystonia arising from neurodegeneration with brain iron accumulation. Nuclear medicine communications, 2015, Volume: 36, Issue:5 Topics: Adolescent; Brain; Child; Dystonic Disorders; Female; Fluorodeoxyglucose F18; Humans; Iron; Male; Neurodegenerative Diseases; Positron-Emission Tomography; Retrospective Studies; Young Adult	2015
Deficient vesicular storage: A common theme in catecholaminergic neurodegeneration. Parkinsonism & related disorders, 2015, Volume: 21, Issue:9 Topics: Autopsy; Catecholamines; Fluorodeoxyglucose F18; Humans; Levodopa; Neurodegenerative Diseases; Neurons; Parkinson Disease; Putamen; Synaptic Vesicles	2015
Metabolic Topology of Neurodegenerative Disorders: Influence of Cognitive and Motor Deficits. Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2015, Volume: 56, Issue:12 Topics: Aged; Alzheimer Disease; Brain Mapping; Cognition; Cognitive Dysfunction; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Lewy Body Disease; Male; Movement Disorders; Neurodegenerative Diseases; Parkinson Disease; Parkinson Disease, Postencephalitic; Radionuclide Imaging; Radiopharmaceuticals	2015
Role of β-Amyloidosis and Neurodegeneration in Subsequent Imaging Changes in Mild Cognitive Impairment. JAMA neurology, 2015, Volume: 72, Issue:12 Topics: Aged; Aged, 80 and over; Alzheimer Disease; Amyloidosis; Aniline Compounds; Cognitive Dysfunction; Cohort Studies; Disease Progression; Female; Fluorodeoxyglucose F18; Gray Matter; Humans; Male; Neurodegenerative Diseases; Positron-Emission Tomography; Thiazoles	2015
Based on the Network Degeneration Hypothesis: Separating Individual Patients with Different Neurodegenerative Syndromes in a Preliminary Hybrid PET/MR Study. Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2016, Volume: 57, Issue:3 Topics: Aged; Aged, 80 and over; Alzheimer Disease; Aphasia, Broca; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Frontotemporal Lobar Degeneration; Humans; Image Processing, Computer-Assisted; Magnetic Resonance Imaging; Male; Multimodal Imaging; Nerve Net; Neurodegenerative Diseases; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Reproducibility of Results	2016
Boosting brain glucose metabolism to fight neurodegeneration? Oncotarget, 2017, Feb-28, Volume: 8, Issue:9 Topics: Amyloid beta-Peptides; Animals; Arachidonic Acids; Brain; Cyclooxygenase 2; Dementia; Endocannabinoids; Fluorodeoxyglucose F18; Glucose; Hippocampus; Humans; Insulin; Ligands; Mice; Mice, Transgenic; Neurodegenerative Diseases; Neurons; Polyunsaturated Alkamides; Positron-Emission Tomography; Protein Folding; Receptor, Cannabinoid, CB2; Signal Transduction	2017
Evaluation of an optimized [ European journal of neurology, 2017, Volume: 24, Issue:5 Topics: Aged; Aged, 80 and over; Basal Ganglia Diseases; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Male; Middle Aged; Neurodegenerative Diseases; Parkinsonian Disorders; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity	2017
A novel insertional mutation in the prion protein gene: clinical and bio-molecular findings. Journal of neurology, neurosurgery, and psychiatry, 2008, Volume: 79, Issue:12 Topics: Adult; Brain; Cloning, Molecular; Cognition Disorders; Dementia; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Models, Genetic; Mutation; Neurodegenerative Diseases; Prion Proteins; Prions; Radiopharmaceuticals; Recombinant Proteins	2008
Acute toxicity of two Alzheimer's disease radiopharmaceuticals: FDDNP and IMPY. Drug and chemical toxicology, 2009, Volume: 32, Issue:4 Topics: Alzheimer Disease; Amyloid beta-Peptides; Animals; Brain; Dementia; Female; Fluorescent Dyes; Fluorodeoxyglucose F18; Humans; Image Enhancement; Male; Neurodegenerative Diseases; Neurofibrillary Tangles; Pyrazoles; Radiopharmaceuticals; Tissue Distribution	2009
B-spline-based stereotactical normalization of brain FDG PET scans in suspected neurodegenerative disease: impact on voxel-based statistical single-subject analysis. NeuroImage, 2010, Apr-15, Volume: 50, Issue:3 Topics: Adult; Aged; Aged, 80 and over; Alzheimer Disease; Area Under Curve; Brain; Computer Simulation; Dementia; Female; Fluorodeoxyglucose F18; Frontotemporal Dementia; Humans; Lewy Body Disease; Male; Middle Aged; Models, Statistical; Neurodegenerative Diseases; Positron-Emission Tomography; ROC Curve; Signal Processing, Computer-Assisted	2010
Typical cerebral metabolic patterns in neurodegenerative brain diseases. Movement disorders : official journal of the Movement Disorder Society, 2010, Oct-30, Volume: 25, Issue:14 Topics: Aged; Brain; Brain Diseases; Brain Mapping; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Male; Middle Aged; Neurodegenerative Diseases; Positron-Emission Tomography; Retrospective Studies	2010
Characterizing a neurodegenerative syndrome: primary progressive apraxia of speech. Brain : a journal of neurology, 2012, Volume: 135, Issue:Pt 5 Topics: Aged; Aged, 80 and over; Aniline Compounds; Apraxias; Brain; Diffusion Magnetic Resonance Imaging; Disease Progression; Female; Fluorodeoxyglucose F18; Humans; Language Tests; Male; Middle Aged; Neurodegenerative Diseases; Neurologic Examination; Neuropsychological Tests; Positron-Emission Tomography; Speech Disorders; Thiazoles; Tomography, X-Ray Computed	2012
PET and MRI reveal early evidence of neurodegeneration in spinocerebellar ataxia type 17. Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2012, Volume: 53, Issue:7 Topics: Adult; Age of Onset; Brain; Dopamine Agents; Dopamine Antagonists; Dopaminergic Neurons; Female; Fluorodeoxyglucose F18; Glucose; Heterozygote; Humans; Image Processing, Computer-Assisted; Magnetic Resonance Imaging; Male; Methylphenidate; Middle Aged; Mutation; Neurodegenerative Diseases; Neuropsychological Tests; Positron-Emission Tomography; Raclopride; Radiopharmaceuticals; Spinocerebellar Ataxias	2012
A case of Creutzfeldt-Jakob disease mimicking corticobasal degeneration: FDG PET, SPECT, and MRI findings. Clinical nuclear medicine, 2012, Volume: 37, Issue:7 Topics: Cerebral Cortex; Creutzfeldt-Jakob Syndrome; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Middle Aged; Neurodegenerative Diseases; Positron-Emission Tomography; Tomography, Emission-Computed, Single-Photon	2012
Progressive neuropsychiatric and brain abnormalities after smoke inhalation. BMJ case reports, 2012, Aug-08, Volume: 2012 Topics: Activities of Daily Living; Brain; Cognition Disorders; Depressive Disorder, Major; DNA Damage; Fluorodeoxyglucose F18; Fructose; Humans; Male; Memory, Long-Term; Methylphenidate; Middle Aged; Neurodegenerative Diseases; Neuropsychological Tests; Oxidative Stress; Positron-Emission Tomography; Radiopharmaceuticals; Sertraline; Smoke Inhalation Injury; Time Factors; Topiramate; Valproic Acid	2012
[¹⁸F]FDG-PET is superior to [¹²³I]IBZM-SPECT for the differential diagnosis of parkinsonism. Neurology, 2012, Sep-25, Volume: 79, Issue:13 Topics: Aged; Diagnosis, Differential; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Iodobenzenes; Lewy Body Disease; Male; Middle Aged; Multiple System Atrophy; Neurodegenerative Diseases; Parkinson Disease; Parkinsonian Disorders; Positron-Emission Tomography; Supranuclear Palsy, Progressive; Tomography, Emission-Computed, Single-Photon	2012
Progression to dementia in clinical subtypes of mild cognitive impairment. Dementia and geriatric cognitive disorders, 2006, Volume: 22, Issue:1 Topics: Aged; Amnesia; Brain Chemistry; Cognition Disorders; Dementia; Disease Progression; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Glucose; Humans; Logistic Models; Male; Middle Aged; Neurodegenerative Diseases; Neuropsychological Tests; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies	2006
Extrapyramidal symptoms in Wilson's disease are associated with olfactory dysfunction. Movement disorders : official journal of the Movement Disorder Society, 2006, Volume: 21, Issue:9 Topics: Adult; Aged; Basal Ganglia; Basal Ganglia Diseases; Blood Glucose; Chromosome Aberrations; Copper; Extrapyramidal Tracts; Female; Fluorodeoxyglucose F18; Genes, Recessive; Hepatolenticular Degeneration; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Neurodegenerative Diseases; Olfaction Disorders; Olfactory Pathways; Parkinsonian Disorders; Positron-Emission Tomography; Sensory Thresholds; Statistics as Topic	2006
18F-FDG PET in neurodegenerative Langerhans cell histiocytosis : results and potential interest for an early diagnosis of the disease. Journal of neurology, 2008, Volume: 255, Issue:4 Topics: Adolescent; Adult; Aged; Brain; Brain Mapping; Cerebellar Ataxia; Cognition Disorders; Diagnosis, Differential; Early Diagnosis; Female; Fluorodeoxyglucose F18; Histiocytosis, Langerhans-Cell; Humans; Male; Middle Aged; Motor Neuron Disease; Neurodegenerative Diseases; Positron-Emission Tomography; Predictive Value of Tests; Prognosis	2008
Clinical and brain 18fluoro-2-deoxyglucose positron emission tomographic findings in ethylmalonic aciduria, a progressive neurometabolic disease. European journal of paediatric neurology : EJPN : official journal of the European Paediatric Neurology Society, 1999, Volume: 3, Issue:3 Topics: Caudate Nucleus; Child, Preschool; Fluorodeoxyglucose F18; Frontal Lobe; Humans; Magnetic Resonance Imaging; Male; Malonates; Metabolism, Inborn Errors; Neurodegenerative Diseases; Putamen; Radiopharmaceuticals; Tomography, Emission-Computed	1999
Contribution of PET studies in diagnosis of corticobasal degeneration. European neurology, 2000, Volume: 44, Issue:1 Topics: Aged; Basal Ganglia; Blood Glucose; Brain Mapping; Cerebral Cortex; Dominance, Cerebral; Energy Metabolism; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Motor Cortex; Neurodegenerative Diseases; Neurologic Examination; Thalamus; Tomography, Emission-Computed	2000
Voxel-based distribution of metabolic impairment in corticobasal degeneration. Movement disorders : official journal of the Movement Disorder Society, 2000, Volume: 15, Issue:5 Topics: Adult; Aged; Aged, 80 and over; Basal Ganglia Diseases; Blood Glucose; Brain; Brain Diseases, Metabolic; Case-Control Studies; Energy Metabolism; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Nerve Net; Neurodegenerative Diseases; Radiopharmaceuticals; Supranuclear Palsy, Progressive; Tomography, Emission-Computed	2000